Key facts
- This page summarizes Anastasios Gianakakos's Form 4 filing for LianBio (LIANY).
- 1 reported transaction and 1 derivative row are listed below.
- Filing timestamp: 27 Jun 2022, 16:17.
Anastasios Gianakakos - 23 Jun 2022 Form 4 Insider Report for LianBio (LIANY)
- Role
- Director
- Signature
- By: /s/ Angela Chen, Attorney-in-Fact
- Issuer symbol
- LIANY
- Transactions as of
- 23 Jun 2022
- Net transactions value
- $0
- Form type
- 4
- Filing time
- 27 Jun 2022, 16:17:56 UTC
- Previous filing
- 03 Jan 2022
- Next filing
- 23 Jun 2023
- SEC
- View on sec.gov
Key filing fact
Anastasios Gianakakos filed Form 4 for LianBio (LIANY) on 27 Jun 2022.
Change
- Previous filing in this sequence was filed on 03 Jan 2022.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
See Original Filing
Ownership activity is grounded in SEC Form 4 disclosures.
Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)
LIAN
transaction
Derivative
Ordinary Shares
Award
- Transaction value
- $0
- Shares
- +36,300
- Change %
- Price
- $0.000000
- Shares after
- 36,300
- Date
- 23 Jun 2022
- Ownership
- Direct
- Underlying class
- Ordinary Shares
- Underlying amount
- 36,300
- Exercise price
- $2.52
- Footnotes
- F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
Explanation of Responses:
| Id | Content |
|---|---|
| F1 | The shares underlying the option shall vest and become exercisable in full on June 23, 2023, the first anniversary of the grant date, subject to the Reporting Person providing continuous service to the Issuer through such date. |